Pietrantoni Celestino DO - Buffalo, New York 14221

Pietrantoni Celestino DO is categorized under Doctors in Buffalo, NY .

Business Name: Pietrantoni Celestino DO
Contact Person: Celestino Pietrantoni
Address: 6460 Main St, Buffalo, New York 14221
Phone Number: (716) 634-5100
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Hays Thomas MD - Buffalo, NY 14221
Morrison Diane H MD - Buffalo, NY 14221
Weppner Dennis M MD - Buffalo, NY 14221
Nabi Sayeed MD - Buffalo, NY 14221
Zborowski Michael PhD - Buffalo, NY 14221
Phang James C MD - Buffalo, NY 14221
Mary Mcgorray - Buffalo, NY 14221
Pasquale A Greco - Buffalo, NY 14221
Rebecca Sorley - Buffalo, NY 14221
Travelers Health & Immunizatio - Buffalo, NY 14221
Buffalo Medical Group - Buffalo, NY 14221
Marfurt Jean Ann M MD - Buffalo, NY 14221
Costich Theodore G MD - Buffalo, NY 14221
Pepe Marjorie R MD - Buffalo, NY 14221
Joseph E Buran - Buffalo, NY 14221
Chatrath Kapil MD - Buffalo, NY 14221
Otolarynglolgy Group Pc - Buffalo, NY 14221
Stevens Pamela L MD - Buffalo, NY 14221
Janet H Sung - Buffalo, NY 14221
Kalb Robert E MD - Buffalo, NY 14221

The company Pietrantoni Celestino DO provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Pietrantoni Celestino DO, and the business now earns $500.000 to $999.999 per annum.

Pietrantoni Celestino DO was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Pietrantoni Celestino DO, please call Celestino Pietrantoni with the phone number (716) 634-5100 or visit its single location at 6460 Main St in Buffalo, New York 14221.

The location of the single location can also be found using the coordinates 42.96602,-78.71292. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.